Why Poland
Home > Why Poland > Sectors > MedTech

Arabia SaudyjskaMedTech Sector

Support for Investors:
Centre for Strategic Investment
e-mail: invest@paih.gov.pl

Large, fast-growing domestic market

  • Large, aging population - 38.3m
  • Largest CEE medical device market - USD 11bn, forecast to reach USD 13.8bn in 2024
  • Growing private healthcare sector - 7% CAGR in years 2016-2021
  • Highest health expenditure in CEE - USD 38.2bn
  • Market growing at 10.1% CAGR 2019-2024 in USD terms - 2x the Global CAGR
  • 6,2% of GDP spent on healthcare going up to 7% by 2027 according to the Government’s policy
Sources: GUS; OECD data, Q3 2020; PMR; MedTech Europe Report 2020; Fitch Solutions MedTech Industry Report

Attractive MedTech hub

  • EU membership
    EU member since 2004 with strong links to eurozone, ensuring same quality standards
  • Most resilient to COVID crisis in the EU
    Polish economy reported the smallest drop in GDP dynamics among the EU countries
  • Fast exports growth
    Growing MedTech production, with exports increasing by 18.9% in 2018
  • 4th largest talent pool in EU
    Availability of highly skilled employees, large and well educated labor force
  • Fast-growing domestic companies
    Revenues of domestic companies increased by 30% between 2014 and 2018
  • >80% of train transports between China-EU go through Poland
    Logistics bridge between East and West, proximity to customers

Sources: OECD statistics; Press research; Puls Biznesu and Spotdata Report “Polish MedTech - chances and illustions”; Bloomberg; InfoCredit

Innovation booster

  • Regulations in line with EU legislation
  • Governmental incentives for R&D
  • Large MedTech student pool
  • Big testing base - 11 million patients a year
  • High growth of R&D centers, +300 in past few years
  • Synergies with strong IT sector

"Poland has an immense pool of talent and is a hotbed for innovation that continues to grow."

"Poland’s overlapping business hours with all of our R&D centres around the world definitely facilitates flawless global operations."

Frank Konings, COO, Johnson & Johnson

Sources: GUS; OECD statistics; Press research; Puls Biznesu and Spotdata Report “Polish MedTech - chances and illustions”; jnjpoland.pl

Lively Polish MedTech environment

  • CRO R&D
    Total CRO: 50
    Paraxel, ICON, Novartis, PRA, PSI, Roche, Pfizer
  • Startups
    Around 100 MedTech startups
    Among others - StethoMe, Pregnabit, MedApp
  • Universities
    + 64 thousand medical students each year
    Dedicated MedTech studies: 3D Technologies in Medicine, Biocybernetics, Bioengineering, Neuroinformatics, IT in Medicine&Pharma
Sources: Crido Report “R&D market in Poland”; badaniaklinicznewpolsce.pl; laboratoria.net

Return »

Polish Investment and Trade Agency

Krucza St. 50

00-025 Warsaw

All rights reserved. Legal disclaimer

This website uses cookies. Use of this site constitutes agreement to the record or use.
For more information, see our Privacy Policy. You can find out more about which cookies we are using or switch them off in settings.
I accept the Privacy Policy zamknij